Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

A Brief Overview of the Oral Delivery of Insulin as an Alternative to the Parenteral Delivery.

Macedo A, Filipe P, Thomé NG, Vieira J, Oliveira C, Teodósio C, Ferreira R, Roque L, Fonte P.

Curr Mol Med. 2020;20(2):134-143. doi: 10.2174/1566524019666191010095522.

PMID:
31965934
2.

Corrigendum to "Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage" [Clin Immunol 2018; 197: 224-230].

van den Bossche WBL, Rykov K, Teodosio C, Ten Have BLEF, Knobben BAS, Sietsma MS, Josiassen K, de Bruin-Versteeg S, Orfao A, van Dongen JJM, van Raay JJAM.

Clin Immunol. 2020 Jan 19:108344. doi: 10.1016/j.clim.2020.108344. [Epub ahead of print] No abstract available.

PMID:
31964597
3.

Immunophenotypic dissection of normal hematopoiesis.

Orfao A, Matarraz S, Pérez-Andrés M, Almeida J, Teodosio C, Berkowska MA, van Dongen JJM; EuroFlow.

J Immunol Methods. 2019 Dec;475:112684. doi: 10.1016/j.jim.2019.112684. Epub 2019 Oct 30. Review.

PMID:
31676343
4.

The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with age.

Muggen AF, de Jong M, Wolvers-Tettero ILM, Kallemeijn MJ, Teodósio C, Darzentas N, Stadhouders R, IJspeert H, van der Burg M, van IJcken WF, Verhaar JAN, Abdulahad WH, Brouwer E, Boots AMH, Hendriks RW, van Dongen JJM, Langerak AW.

Immun Ageing. 2019 Aug 28;16:22. doi: 10.1186/s12979-019-0163-x. eCollection 2019.

5.

Impact of blood storage and sample handling on quality of high dimensional flow cytometric data in multicenter clinical research.

Diks AM, Bonroy C, Teodosio C, Groenland RJ, de Mooij B, de Maertelaere E, Neirynck J, Philippé J, Orfao A, van Dongen JJM, Berkowska MA.

J Immunol Methods. 2019 Dec;475:112616. doi: 10.1016/j.jim.2019.06.007. Epub 2019 Jun 7.

6.

Distribution of subsets of blood monocytic cells throughout life.

Damasceno D, Teodosio C, van den Bossche WBL, Perez-Andres M, Arriba-Méndez S, Muñoz-Bellvis L, Romero A, Blanco JF, Remesal A, Puig N, Matarraz S, Vicente-Villardón JL, van Dongen JJM, Almeida J, Orfao A; TiMaScan Study Group.

J Allergy Clin Immunol. 2019 Jul;144(1):320-323.e6. doi: 10.1016/j.jaci.2019.02.030. Epub 2019 Mar 16. No abstract available.

7.

Maturation-associated gene expression profiles during normal human bone marrow erythropoiesis.

Mello FV, Land MGP, Costa ES, Teodósio C, Sanchez ML, Bárcena P, Peres RT, Pedreira CE, Alves LR, Orfao A.

Cell Death Discov. 2019 Feb 28;5:69. doi: 10.1038/s41420-019-0151-0. eCollection 2019.

8.

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis.

Dasilva-Freire N, Mayado A, Teodosio C, Jara-Acevedo M, Álvarez-Twose I, Matito A, Sánchez-Muñoz L, Caldas C, Henriques A, Muñoz-González JI, García-Montero AC, Sánchez-Gallego JI, Escribano L, Orfao A.

Int J Mol Sci. 2019 Jan 28;20(3). pii: E552. doi: 10.3390/ijms20030552.

9.

Naturally Occurring Plectranthus-derived Diterpenes with Antitumoral Activities.

Garcia C, Teodósio C, Oliveira C, Oliveira C, Díaz-Lanza A, Reis C, Duarte N, Rijo P.

Curr Pharm Des. 2018;24(36):4207-4236. doi: 10.2174/1381612825666190115144241. Review.

PMID:
30644340
10.

Improving the Reliability of V-Wave Responses in the Soleus Muscle.

Mendonca GV, Teodósio C, Mouro M, Freitas S, Mil-Homens P, Pezarat-Correia P, Vila-Chã C.

J Clin Neurophysiol. 2019 Mar;36(2):97-103. doi: 10.1097/WNP.0000000000000560.

PMID:
30624286
11.

Impact of somatic and germline mutations on the outcome of systemic mastocytosis.

Muñoz-González JI, Jara-Acevedo M, Alvarez-Twose I, Merker JD, Teodosio C, Hou Y, Henriques A, Roskin KM, Sanchez-Muñoz L, Tsai AG, Caldas C, Matito A, Sánchez-Gallego JI, Mayado A, Dasilva-Freire N, Gotlib JR, Escribano L, Orfao A, García-Montero AC.

Blood Adv. 2018 Nov 13;2(21):2814-2828. doi: 10.1182/bloodadvances.2018020628.

12.

Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage.

van den Bossche WBL, Rykov K, Teodosio C, Ten Have BLEF, Knobben BAS, Sietsma MS, Josiassen K, de Bruin-Versteeg S, Orfao A, van Dongen JJM, van Raay JJAM.

Clin Immunol. 2018 Dec;197:224-230. doi: 10.1016/j.clim.2018.09.014. Epub 2018 Oct 2. Erratum in: Clin Immunol. 2020 Jan 19;:108344.

PMID:
30290225
13.

Muscle fatigue in response to low-load blood flow-restricted elbow-flexion exercise: are there any sex differences?

Mendonca GV, Borges A, Teodósio C, Matos P, Correia J, Vila-Chã C, Mil-Homens P, Pezarat-Correia P.

Eur J Appl Physiol. 2018 Oct;118(10):2089-2096. doi: 10.1007/s00421-018-3940-x. Epub 2018 Jul 13.

PMID:
30006670
14.

Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.

van den Bossche WBL, Kleijn A, Teunissen CE, Voerman JSA, Teodosio C, Noske DP, van Dongen JJM, Dirven CMF, Lamfers MLM.

Neuro Oncol. 2018 Oct 9;20(11):1494-1504. doi: 10.1093/neuonc/noy082.

15.

Sexual Dimorphism in the Estimation of Upper-Limb Blood Flow Restriction in the Seated Position.

Borges A, Teodósio C, Matos P, Mil-Homens P, Pezarat-Correia P, Fahs C, Mendonca GV.

J Strength Cond Res. 2018 Jul;32(7):2096-2102. doi: 10.1519/JSC.0000000000002582.

PMID:
29570573
16.

Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome.

Criado I, Rodríguez-Caballero A, Gutiérrez ML, Pedreira CE, Alcoceba M, Nieto W, Teodosio C, Bárcena P, Romero A, Fernández-Navarro P, González M, Almeida J, Orfao A; Primary Health Care Group of Salamanca for the Study of MBL.

Haematologica. 2018 Jul;103(7):1198-1208. doi: 10.3324/haematol.2017.183954. Epub 2018 Mar 22.

17.

Characterization of CD34+ hematopoietic cells in systemic mastocytosis: Potential role in disease dissemination.

Mayado A, Teodosio C, Dasilva-Freire N, Jara-Acevedo M, Garcia-Montero AC, Álvarez-Twose I, Sánchez-Muñoz L, Matito A, Caldas C, Muñoz-González JI, Henriques A, Sánchez-Gallego JI, Escribano L, Orfao A.

Allergy. 2018 Jun;73(6):1294-1304. doi: 10.1111/all.13413. Epub 2018 Feb 13.

PMID:
29331029
18.

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.

Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, García-Macías MDC, Sevillano V, Alonso D, Pascual-Pasto G, San-Segundo L, Vila-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J, de Álava E.

Oncotarget. 2017 Jun 27;8(26):43592. doi: 10.18632/oncotarget.18610. No abstract available.

19.

Sexual dimorphism in heart rate recovery from peak exercise.

de Mendonca GV, Teodósio C, Bruno PM.

Eur J Appl Physiol. 2017 Jul;117(7):1373-1381. doi: 10.1007/s00421-017-3627-8. Epub 2017 May 3.

PMID:
28470411
20.

Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples.

van der Velden VHJ, Flores-Montero J, Perez-Andres M, Martin-Ayuso M, Crespo O, Blanco E, Kalina T, Philippé J, Bonroy C, de Bie M, Te Marvelde J, Teodosio C, Corral Mateos A, Kanderová V, van der Burg M, Van Hoof D, van Dongen JJM, Orfao A.

J Immunol Methods. 2019 Dec;475:112287. doi: 10.1016/j.jim.2017.03.011. Epub 2017 Mar 22.

21.

Maturation-associated gene expression profiles along normal human bone marrow monopoiesis.

Mello FV, Alves LR, Land MG, Teodósio C, Sanchez ML, Bárcena P, Peres RT, Pedreira CE, Costa ES, Orfao A.

Br J Haematol. 2017 Feb;176(3):464-474. doi: 10.1111/bjh.14467. Epub 2017 Jan 12.

PMID:
28079251
22.

Comprehensive and Systematic Analysis of the Immunocompatibility of Polyelectrolyte Capsules.

Zyuzin MV, Díez P, Goldsmith M, Carregal-Romero S, Teodosio C, Rejman J, Feliu N, Escudero A, Almendral MJ, Linne U, Peer D, Fuentes M, Parak WJ.

Bioconjug Chem. 2017 Feb 15;28(2):556-564. doi: 10.1021/acs.bioconjchem.6b00657. Epub 2017 Jan 20.

PMID:
28040889
23.

Expression profile of novel cell surface molecules on different subsets of human peripheral blood antigen-presenting cells.

Damasceno D, Andrés MP, van den Bossche WB, Flores-Montero J, de Bruin S, Teodosio C, van Dongen JJ, Orfao A, Almeida J.

Clin Transl Immunology. 2016 Sep 16;5(9):e100. eCollection 2016 Sep.

24.

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.

Alvarez-Twose I, Matito A, Morgado JM, Sánchez-Muñoz L, Jara-Acevedo M, García-Montero A, Mayado A, Caldas C, Teodósio C, Muñoz-González JI, Mollejo M, Escribano L, Orfao A.

Oncotarget. 2016 Jul 19;8(40):68950-68963. doi: 10.18632/oncotarget.10711. eCollection 2017 Sep 15.

25.

Sexual dimorphism in the osmopressor response following water ingestion.

Mendonca GV, Teodósio C, Lucena R, Pereira FD.

Biosci Rep. 2016 Jun 17;36(3). pii: e00344. doi: 10.1042/BSR20150276. Print 2016 Jul.

26.

KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression.

Garcia-Montero AC, Jara-Acevedo M, Alvarez-Twose I, Teodosio C, Sanchez-Muñoz L, Muñiz C, Muñoz-Gonzalez JI, Mayado A, Matito A, Caldas C, Morgado JM, Escribano L, Orfao A.

Blood. 2016 Feb 11;127(6):761-8. doi: 10.1182/blood-2015-07-655100. Epub 2015 Nov 30.

PMID:
26622064
27.

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.

Sánchez-Muñoz L, Morgado JM, Álvarez-Twose I, Matito A, Garcia-Montero AC, Teodosio C, Jara-Acevedo M, Mayado A, Mollejo M, Caldas C, González de Olano D, Escribano L, Orfao A.

Br J Haematol. 2016 Jan;172(1):56-63. doi: 10.1111/bjh.13789. Epub 2015 Oct 12.

PMID:
26456532
28.

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow.

Muñiz C, Teodosio C, Mayado A, Amaral AT, Matarraz S, Bárcena P, Sanchez ML, Alvarez-Twose I, Diez-Campelo M, García-Montero AC, Blanco JF, Del Cañizo MC, del Pino Montes J, Orfao A.

Stem Cell Res Ther. 2015 Sep 7;6:169. doi: 10.1186/s13287-015-0152-8.

29.

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression.

Mayado A, Teodosio C, Garcia-Montero AC, Matito A, Rodriguez-Caballero A, Morgado JM, Muñiz C, Jara-Acevedo M, Álvarez-Twose I, Sanchez-Muñoz L, Matarraz S, Caldas C, Muñoz-González JI, Escribano L, Orfao A.

Leukemia. 2016 Jan;30(1):124-30. doi: 10.1038/leu.2015.176. Epub 2015 Jul 8.

PMID:
26153655
30.

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

Álvarez-Twose I, Jara-Acevedo M, Morgado JM, García-Montero A, Sánchez-Muñoz L, Teodósio C, Matito A, Mayado A, Caldas C, Mollejo M, Orfao A, Escribano L.

J Allergy Clin Immunol. 2016 Jan;137(1):168-178.e1. doi: 10.1016/j.jaci.2015.05.008. Epub 2015 Jun 19.

PMID:
26100086
31.

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.

Jara-Acevedo M, Teodosio C, Sanchez-Muñoz L, Álvarez-Twose I, Mayado A, Caldas C, Matito A, Morgado JM, Muñoz-González JI, Escribano L, Garcia-Montero AC, Orfao A.

Mod Pathol. 2015 Aug;28(8):1138-49. doi: 10.1038/modpathol.2015.72. Epub 2015 Jun 12.

32.

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.

Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pasto G, San-Segundo L, Vila-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J, de Álava E.

Oncotarget. 2015 Aug 7;6(22):18875-90. doi: 10.18632/oncotarget.4303. Erratum in: Oncotarget. 2017 Jun 27;8(26):43592.

33.

Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas.

Gutiérrez ML, Corchete L, Teodosio C, Sarasquete ME, del Mar Abad M, Iglesias M, Esteban C, Sayagues JM, Orfao A, Muñoz-Bellvis L.

Oncotarget. 2015 Aug 7;6(22):19070-86.

34.

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis.

Teodosio C, Mayado A, Sánchez-Muñoz L, Morgado JM, Jara-Acevedo M, Álvarez-Twose I, García-Montero AC, Matito A, Caldas C, Escribano L, Orfao A.

J Leukoc Biol. 2015 Jan;97(1):49-59. doi: 10.1189/jlb.5RU0614-296R. Epub 2014 Nov 7. Review.

PMID:
25381388
35.

Identification and immunophenotypic characterization of normal and pathological mast cells.

Morgado JM, Sánchez-Muñoz L, Teodósio C, Escribano L.

Methods Mol Biol. 2014;1192:205-26. doi: 10.1007/978-1-4939-1173-8_16.

PMID:
25149495
36.

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.

Sánchez-Muñoz L, Teodosio C, Morgado JM, Perbellini O, Mayado A, Alvarez-Twose I, Matito A, Jara-Acevedo M, García-Montero AC, Orfao A, Escribano L.

Immunol Allergy Clin North Am. 2014 May;34(2):297-313. doi: 10.1016/j.iac.2014.01.008. Review.

PMID:
24745675
37.

The protein expression profile of meningioma cells is associated with distinct cytogenetic tumour subgroups.

Domingues PH, Teodósio C, Otero Á, Sousa P, Gonçalves JM, Nieto AB, Lopes MC, de Oliveira C, Orfao A, Tabernero MD.

Neuropathol Appl Neurobiol. 2015 Apr;41(3):319-32. doi: 10.1111/nan.12127.

PMID:
24612434
38.

Impact of allergic rhinitis and specific subcutaneous immunotherapy on peripheral blood basophils of patients sensitized to Dermatophagoides pteronyssinus.

Lopes A, Azenha P, Teodósio C, Inácio M, Silva I, Loureiro G, Martinho A, Luís AS, Trindade H, Pereira C, Paiva A.

Allergy Asthma Clin Immunol. 2013 Oct 11;9(1):40. doi: 10.1186/1710-1492-9-40.

39.

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome.

Matito A, Morgado JM, Álvarez-Twose I, Sánchez-Muñoz L, Pedreira CE, Jara-Acevedo M, Teodosio C, Sánchez-López P, Fernández-Núñez E, Moreno-Borque R, García-Montero A, Orfao A, Escribano L.

PLoS One. 2013 Oct 14;8(10):e76116. doi: 10.1371/journal.pone.0076116. eCollection 2013.

40.

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.

Morgado JM, Perbellini O, Johnson RC, Teodósio C, Matito A, Álvarez-Twose I, Bonadonna P, Zamò A, Jara-Acevedo M, Mayado A, Garcia-Montero A, Mollejo M, George TI, Zanotti R, Orfao A, Escribano L, Sánchez-Muñoz L.

Histopathology. 2013 Dec;63(6):780-7. doi: 10.1111/his.12221. Epub 2013 Sep 20.

PMID:
24111625
41.

Association between inflammatory infiltrates and isolated monosomy 22/del(22q) in meningiomas.

Domingues PH, Teodósio C, Otero Á, Sousa P, Ortiz J, Macias Mdel C, Gonçalves JM, Nieto AB, Lopes MC, de Oliveira C, Orfao A, Tabernero MD.

PLoS One. 2013 Oct 1;8(10):e74798. doi: 10.1371/journal.pone.0074798. eCollection 2013.

42.

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

Alvarez-Twose I, Zanotti R, González-de-Olano D, Bonadonna P, Vega A, Matito A, Sánchez-Muñoz L, Morgado JM, Perbellini O, García-Montero A, De Matteis G, Teodósio C, Rossini M, Jara-Acevedo M, Schena D, Mayado A, Zamò A, Mollejo M, Sánchez-López P, Cabañes N, Orfao A, Escribano L; Spanish Network on Mastocytosis (REMA); Italian Network on Mastocytosis (RIMA).

J Allergy Clin Immunol. 2014 Feb;133(2):520-8. doi: 10.1016/j.jaci.2013.06.020. Epub 2013 Aug 6.

PMID:
23921094
43.

Flow cytometry criteria for systemic mastocytosis: bone marrow mast cell counts do not always count.

Sánchez-Muñoz L, Morgado JM, Alvarez-Twose I, Matito A, Escribano L, Teodosio C, Jara-Acevedo M, García-Montero AC, Mayado A, Orfao A.

Am J Clin Pathol. 2013 Mar;139(3):404-6. No abstract available.

PMID:
23547320
44.

Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis.

Teodosio C, García-Montero AC, Jara-Acevedo M, Sánchez-Muñoz L, Pedreira CE, Álvarez-Twose I, Matarraz S, Morgado JM, Bárcena P, Matito A, Mayado A, Sanchez ML, Diez-Campelo M, Escribano L, Orfao A.

J Allergy Clin Immunol. 2013 Apr;131(4):1213-24, 1224.e1-4. doi: 10.1016/j.jaci.2012.12.674. Epub 2013 Feb 10.

PMID:
23403045
45.

Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.

Domingues PH, Teodósio C, Ortiz J, Sousa P, Otero A, Maillo A, Bárcena P, García-Macias MC, Lopes MC, de Oliveira C, Orfao A, Tabernero MD.

Am J Pathol. 2012 Nov;181(5):1749-61. doi: 10.1016/j.ajpath.2012.07.033. Epub 2012 Sep 13.

PMID:
22982440
46.

The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome.

Matarraz S, Teodosio C, Fernandez C, Albors M, Jara-Acevedo M, López A, Gonzalez-Gonzalez M, Gutierrez ML, Flores-Montero J, Cerveró C, Pizarro-Perea M, Paz Garrastazul M, Caballero G, Gutierrez O, Mendez GD, González-Silva M, Laranjeira P, Orfao A.

PLoS One. 2012;7(8):e44321. doi: 10.1371/journal.pone.0044321. Epub 2012 Aug 31.

47.

Prognostic Impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas.

González-González M, Muñoz-Bellvis L, Mackintosh C, Fontanillo C, Gutiérrez ML, Abad MM, Bengoechea O, Teodosio C, Fonseca E, Fuentes M, De Las Rivas J, Orfao A, Sayagués JM.

PLoS One. 2012;7(8):e42683. doi: 10.1371/journal.pone.0042683. Epub 2012 Aug 17.

48.

Mast cell-related disorders presenting with Kounis syndrome.

González-de-Olano D, Matito A, Sánchez-López P, Sánchez-Muñoz L, Morgado JM, Teodósio C, Jara-Acevedo M, García-Montero A, Orfao A, Escribano L, Kounis NG, Álvarez-Twose I.

Int J Cardiol. 2012 Nov 1;161(1):56-8. doi: 10.1016/j.ijcard.2012.06.041. Epub 2012 Jun 29. No abstract available.

49.

Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets.

Hauswirth AW, Almeida J, Nieto WG, Teodosio C, Rodriguez-Caballero A, Romero A, López A, Fernandez-Navarro P, Vega T, Perez-Andres M, Valent P, Jäger U, Orfao A; Primary Health Care Group of Salamanca for Study of MBL.

Am J Hematol. 2012 Jul;87(7):721-4. doi: 10.1002/ajh.23214. Epub 2012 Jun 8.

50.

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

Morgado JM, Sánchez-Muñoz L, Teodósio CG, Jara-Acevedo M, Alvarez-Twose I, Matito A, Fernández-Nuñez E, García-Montero A, Orfao A, Escribano L.

Mod Pathol. 2012 Apr;25(4):516-21. doi: 10.1038/modpathol.2011.192. Epub 2012 Jan 6.

Supplemental Content

Loading ...
Support Center